Cyberwhite Ex
FDA Label NDC 11559-004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Estee Lauder Inc for the product Cyberwhite Ex (NDC 11559-004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, warnings, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Otc - Active Ingredient

ACTIVE INGREDIENTS: OCTINOXATE 7.50% [] OCTISALATE 4.00% [] ZINC OXIDE 3.50% [] OXYBENZONE 2.50% [] TITANIUM DIOXIDE 1.10%

Warnings

WARNING: KEEP OUT OF EYES. STOP USE IF IRRITATION OCCURS. KEEP OUT OF REACH OF CHILDREN.

Package Label.Principal Display Panel



PRINCIPAL DISPLAY PANEL

ESTEE LAUDER
CYBER WHITE EX

EXTRA INTENSIVE BB CREME

MULTI-ACTION
FORMULA
SPF 35


1.7 FL OZ. LIQ./50 ML


ESTEE LAUDER DIST.
NEW YORK, NY 10022

ESTEELAUDER.COM
WJRJ
Folding Carton (Wjrjcarton)

Folding Carton (Wjrjcarton)






* Please review the disclaimer below.